175
Views
7
CrossRef citations to date
0
Altmetric
Non-themed Articles

Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet

, &
Pages 769-775 | Received 28 Jan 2015, Accepted 15 Jul 2015, Published online: 14 Aug 2015

References

  • Aslani A, Fattahi F. Formulation, characterization and physicochemical evaluation of potassium citrate effervescent tablets. Adv Pharm Bull 2013;3:217–25
  • Nokhodchi A, Raja S, Patel P, et al. The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts: BI 2012;2:175–87
  • Tazri J, Moghal MMR, Dewan SMR, et al. Formulation and quality determination of indapamide matrix tablet: a thiazide type antihypertensive drug. Adv Pharm Bull 2014;4:191–5
  • Fukami J, Yonemochi E, Yoshihashi Y, et al. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101–9
  • Maya MT, Goncalves NJ, Silva NE, et al. Comparative bioavailability of two immediate release tablets of enalapril/hydrochlorothiazide in healthy volunteers. Eur J Drug Metab Pharmacokinet 2002;27:91–9
  • Lohitnavy M, Lohitnavy O, Wittaya-Areekul S, et al. Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers. Drug Dev Ind Pharm 2003;29:653–9
  • Carpay J, Schoenen J, Ahmad F, et al. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin Ther 2004;26:214–23
  • Flicker F, Betz G. Effect of crospovidone and hydroxypropyl cellulose on carbamazepine in high-dose tablet formulation. Drug Dev Ind Pharm 2012;38:697–705
  • Beri C, Sacher I. Development of fast disintegration tablets as oral drug delivery system – a review. Indian J Pharm 2013;1:80–99
  • Azad M, Arteaga C, Abdelmalek B, et al. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.976574
  • Goyanes A, Souto C, Martínez-Pacheco R. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets. Drug Dev Ind Pharm 2011;37:825–31
  • Dontireddy R, Crean AM. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Dev Ind Pharm 2011;37:1141–9
  • Moad G. Chemical modification of starch by reactive extrusion. Prog Polym Sci 2011;36:218–37
  • Mastropietro DJ, Omidian H. Prevalence and trends of cellulosics in pharmaceutical dosage forms. Drug Dev Ind Pharm 2013;39:382–92
  • Piatkowski M, Bogdal D, Ondruschka B. Microwave-assisted synthesis of poly (aspartic acid). Polimery 2009;54:573–6
  • Ye JH, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev 2001;7:199–213
  • Patel DR, Joshi A, Patel HH, et al. Development and in-vivo evaluation of ondansetron gels for transdermal delivery. Drug Dev Ind Pharm 2015;41:1030–6
  • Park D-M, Song Y-K, Jee J-P, et al. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis. Drug Dev Ind Pharm 2012;38:1077–83
  • Zhao Y, Su H, Fang L, et al. Superabsorbent hydrogels from poly (aspartic acid) with salt-, temperature-and pH-responsiveness properties. Polymer 2005;46:5368–76
  • Wesslén KB, Wesslen B. Synthesis of amphiphilic amylose and starch derivatives. Carbohydr Polym 2002;47:303–11
  • United States Pharmacopeia 32- National Formulary 27 TUSP-mC, Rockville, MD. 2009;4:3138–42
  • Hamishehkar H, Khani S, Kashanian S, et al. Geno-and cytotoxicity of propyl gallate food additive. Drug Chem Toxicol 2014;37:241–6
  • Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. Cytotoxicity and DNA damage properties of tert-butylhydroquinone (TBHQ) food additive. Food Chem 2014;153:315–20
  • United States Pharmacopeia 32- National Formulary 27 TUSP-mC, Rockville, MD. 2009;4:725
  • Morita Y, Tsushima Y, Yasui M, et al. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem Pharm Bull (Tokyo) 2002;50:1181–6
  • Goel H, Rai P, Rana V, et al. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul 2008;2:258–74
  • Desai PM, Liew CV, Heng PW. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus. Int J Pharm 2013;442:65–73
  • European Pharmacopoeia 6.00 CoE, Strasbourg; 2007
  • Wilpiszewska K, Spychaj T. Chemical modification of starch with hexamethylene diisocyanate derivatives. Carbohydr Polym 2007;70:334–40
  • Bashardoust N, Jenita JL, Zakeri-Milani P. Preparation and in vitro investigation of chitosan compressed tablets for colon targeting. Adv Pharm Bull 2011;1:87–92
  • Jelvehgari M, Zakeri-Milani P, Khonsari F. Comparative study of in vitro release and mucoadhesivity of gastric compacts composed of multiple unit system/bilayered discs using direct compression of metformin hydrochloride. Bioimpacts: BI 2014;4:29–38
  • Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33
  • Abdelbary G, Eouani C, Prinderre P, et al. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.